ATH 25.0% 0.3¢ alterity therapeutics limited

they must be confident

  1. 1,166 Posts.
    lightbulb Created with Sketch. 111
    Yahoo finance published this article today.

    http://finance.yahoo.com/news/prana-prepares-next-steps-pbt2-141001892.html

    They are speeding things up.

    The AD extension study could be put forth to FDA perhaps to fast track PBT2 to market without the need for a formal phase 3..... That's me hoping anyway.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.